Content
Search
Navigation
Sitemap
About us
Pipeline & science
Overview
Obesity
Type 2 Diabetes Mellitus (T2DM)
Acute Ischemic Stroke (AIS)
Hypertension
Our expertise
Overview
Our strategic partners
Global opportunities
Join us
Press releases
Contact
简体中文
Search
简体中文
Navigation
Press releases
13 Dec 2023
JIXING’s Milestone! The University of Hong Kong - Shenzhen Hospital issued the first prescription for Varenicline Solution Nasal Spray
Read article
14 Nov 2023
Milestone Pharmaceuticals Presents Positive Results from ReVeRA Phase 2 Study of Etripamil in AFib-RVR at the American Heart Association Scientific Sessions 2023
Read article
06 Nov 2023
JIXING and WuXi STA Announce Strategic Partnership Agreement
Read article
24 Oct 2023
Milestone Pharmaceuticals Announces Submission of New Drug Application to the U.S. FDA for Etripamil
Read article
18 Oct 2023
JIXING Announces National Medical Products Administration Approval of the Clinical Trial Application for the China Cohort of MAPLE-HCM, the Phase 3 Clinical Trial of Aficamten Compared to Metoprolol in Patients with Symptomatic Obstructive Hypertrophic
Read article
11 Oct 2023
Cytokinetics Presents Baseline Characteristics From SEQUOIA-HCM at the HCM Society Scientific Sessions
Read article
Load more
